← Leaderboards
Henry M Sucov
University Of Southern California
$13,339,132
Attributed
$13,339,132
Total exposure
7
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.3M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,339,132 · 7
By mechanism
R01$12,559,482 · 5
R21$779,650 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Cardiac Myocytes”
- Joseph C Wu · Stanford University$53,447,011
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$50,074,770
- Jeffery D Molkentin · Cincinnati Childrens Hosp Med Ctr$40,971,477
- Piero Anversa · New York Medical College$40,584,258
- Junichi Sadoshima · Rutgers Biomedical And Health Sciences$34,907,735
- Steven R Houser · Johns Hopkins University$33,565,081
Research focus
Cardiac MyocytesEmbryoHeartGene ExpressionBaseCardiogenesisAdultEmbryonic HeartMyocardiumNatural RegenerationCellsSignal TransductionLaboratory MouseGenesMorphogenesisTissuesErythropoietinGenetically Modified AnimalsSourceVentricularCardiac RegenerationBlood VesselsNeonatalInjury
Grant awards (35)
The complex genetics of heart regeneration$1,273,956
R01 · FY2025 · HL · contact PI
The complex genetics of heart regeneration$520,970
R01 · FY2022 · HL · contact PI
The complex genetics of heart regeneration$520,970
R01 · FY2021 · HL · contact PI
The complex genetics of heart regeneration$520,970
R01 · FY2020 · HL · contact PI
The complex genetics of heart regeneration$520,970
R01 · FY2019 · HL · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$388,939
R01 · FY2019 · HL · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$427,547
R01 · FY2018 · HL · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$427,547
R01 · FY2017 · HL · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$447,431
R01 · FY2016 · HL · contact PI
Cardiomyocyte heterogeneity and aging$206,250
R21 · FY2016 · AG · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$416,762
R01 · FY2015 · HL · contact PI
Cardiomyocyte heterogeneity and aging$247,500
R21 · FY2015 · AG · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$437,038
R01 · FY2014 · HL · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$485,042
R01 · FY2013 · HL · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$22,181
R01 · FY2013 · HL · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$420,545
R01 · FY2012 · HL · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$403,315
R01 · FY2010 · HL · contact PI
Cardiomyocyte Proliferation and Ventricular Morphogenesis$407,500
R01 · FY2009 · HL · contact PI
TGFb and Cardiac Neural Crest Cell Fate and Function$395,683
R01 · FY2009 · HL · contact PI
TGFb and Cardiac Neural Crest Cell Fate and Function$395,683
R01 · FY2008 · HL · contact PI
TGFb and Cardiac Neural Crest Cell Fate and Function$395,683
R01 · FY2007 · HL · contact PI
TGFb and Cardiac Neural Crest Cell Fate and Function$407,175
R01 · FY2006 · HL · contact PI
Cardiomyocyte Proliferation & Ventricular Morphogenesis$357,034
R01 · FY2006 · HL · contact PI
Cardiomyocyte Proliferation &Ventricular Morphogenesis$365,625
R01 · FY2005 · HL
Cardiomyocyte Proliferation &Ventricular Morphogenesis$365,625
R01 · FY2004 · HL
Retinoic Acid Regulation of Erythropoiesis$243,750
R01 · FY2004 · HL
Cardiomyocyte Proliferation &Ventricular Morphogenesis$365,625
R01 · FY2003 · HL
Retinoic Acid Regulation of Erythropoiesis$243,750
R01 · FY2003 · HL
Cardiomyocyte Proliferation &Ventricular Morphogenesis$365,625
R01 · FY2002 · HL
Retinoic Acid Regulation of Erythropoiesis$243,750
R01 · FY2002 · HL
PATHWAY OF VENTRICULAR MORPHOGENESIS MEDICATED BY RXRA$273,938
R01 · FY2001 · HL
Retinoic Acid Regulation of Erythropoiesis$243,750
R01 · FY2001 · HL
PROSTATE DEVELOPMENT USING CRE RECOMBINASE$162,500
R21 · FY2001 · DK
PATHWAY OF VENTRICULAR MORPHOGENESIS MEDICATED BY RXRA$255,103
R01 · FY2000 · HL
PROSTATE DEVELOPMENT USING CRE RECOMBINASE$163,400
R21 · FY2000 · DK